Johnson & Johnson Is Boring Which Makes Its Dividend Nearly Perfect.
Sixty-four straight years of dividend growth sounds like a headline, but the real story is what keeps that streak alive even as one of JNJ's biggest drugs faces a brutal competitive hit.



















